These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia. Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241 [TBL] [Abstract][Full Text] [Related]
25. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial. Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A; J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849 [TBL] [Abstract][Full Text] [Related]
26. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales. Wolters HA; Knegtering H; van den Bosch RJ; Wiersma D Schizophr Res; 2009 Jul; 112(1-3):114-8. PubMed ID: 19395241 [TBL] [Abstract][Full Text] [Related]
27. The brief psychiatric rating scale: effect of scaling system on clinical response assessment. Thompson PA; Buckley PF; Meltzer HY J Clin Psychopharmacol; 1994 Oct; 14(5):344-6. PubMed ID: 7806691 [TBL] [Abstract][Full Text] [Related]
28. Elevated Clozapine Level Following Acute Infection in a Patient with Schizophrenia: a Case Report. Poon JYK; Tang DYY; Siu BWM; Lui SH East Asian Arch Psychiatry; 2020 Dec; 30(4):120-121. PubMed ID: 33349619 [TBL] [Abstract][Full Text] [Related]
29. The effects of clozapine on negative symptoms in patients with schizophrenia with minimal positive symptoms. Brar JS; Chengappa KN; Parepally H; Sandman AR; Kreinbrook SB; Sheth SA; Ganguli R Ann Clin Psychiatry; 1997 Dec; 9(4):227-34. PubMed ID: 9511946 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and tolerability of clozapine in Japanese patients with treatment-resistant schizophrenia: results from a 12-week, flexible dose study using raters masked to antipsychotic choice. Kishi T; Fujita K; Furukawa O; Suzuki T; Moriwaki M; Nitta M; Hattori M; Tsunoka T; Chekuri R; Kane JM; Correll CU; Iwata N Asian J Psychiatr; 2013 Jun; 6(3):200-7. PubMed ID: 23642976 [TBL] [Abstract][Full Text] [Related]
31. Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial. Takeuchi H; Lee J; Fervaha G; Foussias G; Agid O; Remington G J Clin Psychiatry; 2017 Feb; 78(2):223-228. PubMed ID: 28234436 [TBL] [Abstract][Full Text] [Related]
33. Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study. Kluge M; Schuld A; Himmerich H; Dalal M; Schacht A; Wehmeier PM; Hinze-Selch D; Kraus T; Dittmann RW; Pollmächer T J Clin Psychopharmacol; 2007 Dec; 27(6):662-6. PubMed ID: 18004133 [TBL] [Abstract][Full Text] [Related]
34. Effect size of symptom status in withdrawal of typical antipsychotics and subsequent clozapine treatment in patients with treatment-resistant schizophrenia. Pickar D; Bartko JJ Am J Psychiatry; 2003 Jun; 160(6):1133-8. PubMed ID: 12777272 [TBL] [Abstract][Full Text] [Related]
35. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial. Chang JS; Ahn YM; Park HJ; Lee KY; Kim SH; Kang UG; Kim YS J Clin Psychiatry; 2008 May; 69(5):720-31. PubMed ID: 18370574 [TBL] [Abstract][Full Text] [Related]
36. Clozapine: more side effects but still the best antipsychotic. Kang X; Simpson GM J Clin Psychiatry; 2010 Aug; 71(8):982-3. PubMed ID: 20797378 [No Abstract] [Full Text] [Related]
37. Differential effectiveness of clozapine for patients nonresponsive to or intolerant of first generation antipsychotic medications. Jackson CT; Covell NH; Essock SM Schizophr Bull; 2004; 30(2):219-27. PubMed ID: 15279041 [TBL] [Abstract][Full Text] [Related]
38. A double-blind comparative study of clozapine versus chlorpromazine on Chinese patients with treatment-refractory schizophrenia. Hong CJ; Chen JY; Chiu HJ; Sim CB Int Clin Psychopharmacol; 1997 May; 12(3):123-30. PubMed ID: 9248867 [TBL] [Abstract][Full Text] [Related]
39. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia. Meltzer HY; Bobo WV; Roy A; Jayathilake K; Chen Y; Ertugrul A; Anil Yağcioğlu AE; Small JG J Clin Psychiatry; 2008 Feb; 69(2):274-85. PubMed ID: 18232726 [TBL] [Abstract][Full Text] [Related]
40. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study. Lin CC; Chiu HJ; Chen JY; Liou YJ; Wang YC; Chen TT; Bai YM J Clin Psychopharmacol; 2013 Apr; 33(2):211-4. PubMed ID: 23422395 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]